Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
about
The NF-κB Pathway and Cancer Stem CellsCancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer controlAberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic targetUpdate on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunitiesStress and Non-Stress Roles of Inflammatory Signals during HSC Emergence and MaintenanceA Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology GroupA rationally designed nanoparticle for RNA interference therapy in B-lineage lymphoid malignanciesLoss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells.AMPK-Activated Protein Kinase Suppresses Ccr2 Expression by Inhibiting the NF-κB Pathway in RAW264.7 MacrophagesCurcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.Systematic Genome-wide Screening and Prediction of microRNAs in EBOV During the 2014 Ebolavirus Outbreak.EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4.Correlation between p65 and TNF-α in patients with acute myelocytic leukemia.IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production.Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.A dual role for Caspase8 and NF-κB interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survivalMLL-Rearranged Leukemias-An Update on Science and Clinical Approaches.Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.Regulation of hematopoietic and leukemic stem cells by the immune system.Molecular targets of luteolin in cancerBiology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells.Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction.Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.The role of the proteasome in AML.Leukemic stem cells: identification and clinical application.Genetic polymorphisms of IL-18 rs1946518 and IL-1β rs16944 are associated with prognosis and survival of acute myeloid leukemia.Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia.Meta-Analysis of Gene Expression Profiles in Acute Promyelocytic Leukemia Reveals Involved Pathways.Inhibition of tumor necrosis factor-α enhances apoptosis induced by nuclear factor-κB inhibition in leukemia cells.Fanconi Anemia Mesenchymal Stromal Cells-Derived Glycerophospholipids Skew Hematopoietic Stem Cell Differentiation Through Toll-Like Receptor Signaling.Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells.Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.TNFα and TGFβ-1 synergistically increase the cancer stem cell properties of MiaPaCa-2 cells.MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBPα and inflammatory signaling.Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.Effective targeting of primitive AML CD34+ cells by the second-generation proteasome inhibitor carfilzomib.Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer.
P2860
Q26750605-B265EDE5-F298-45F1-B73E-AC6690A55DEDQ26860058-CFAA021B-3438-475C-B80F-E1CC4E323774Q26995561-5990C989-0C5B-49B9-8FCA-8B68F5A11D14Q28071384-17FBC331-738F-48AE-BFE8-126E5E8C8FD2Q28072920-7E907D34-986C-4CE6-9370-569A2679C9B2Q34585047-3E51BE11-123F-4F6B-9BB5-BC981513954AQ34939490-08D9B70E-4EA8-4668-9F7F-8C55422ED759Q35671776-C030DBAE-6A34-443E-A539-220AA34B1ACBQ35901388-F38B75BB-9874-4E95-AA58-1008C22F91B4Q35977804-FF650F74-7709-4F9F-9BC5-D0B108214263Q36154528-DE535302-22A0-4D9A-8A55-55DC97064566Q36169495-14EAD4B6-B0D0-42B9-BFEE-0754AED3AD4EQ36334400-DBB91ACE-DCA3-4657-96D1-BB11142825BCQ36562157-35C5E16B-A2FF-4382-9F81-6197F93BC2B5Q37022764-ED38102F-EE59-4909-B354-8A47FFE63D6DQ37544113-348FCDDD-978A-4ECE-A6DD-E90592BE9C7CQ37633585-1D27A27E-B223-4FCE-A79B-425F53D5FE32Q37702727-F0A12D3F-A6A0-4B9F-8EE3-2F474FAF5D90Q38225994-539D529E-6A9F-4E43-B244-F95677259026Q38365120-4994E221-D8F1-476A-8C51-F88869D30CCEQ38537879-6F998CA1-F270-44C6-BF1F-9A47F7EDA9D3Q38715325-C4E5F46D-89F8-454B-9E59-CE6679F46906Q38728458-5F5BB8A1-B3A8-4676-B2FF-7E5130C60ED6Q38847748-874ACEC9-4394-4CE6-B5B0-73627B48D6C4Q39027087-0576808E-EDEA-4FBB-885B-8CA7231C600CQ39208298-98E21681-C803-4354-A769-FA6170F24A56Q40436275-0D16D053-2D57-4872-82F8-B7CEB19606C0Q41219902-A828D2BF-287C-4FB8-B9CA-8DCD41FDC5FBQ42044605-1F0FFC10-9D46-4F85-84D8-64C29350F463Q43147639-1B171E45-8405-4FA1-B172-B888E0BE7A67Q43203905-79E61831-BC58-4290-B7EB-8EDD995D8B82Q47099602-28E14134-27AD-41F3-BC2B-3AC3A1598E91Q47116205-08007302-EFAA-4A25-8C1C-95220A96410AQ47136188-8C230769-C55F-4CCC-9C36-B1D0B8D1C374Q48022971-3841AC55-B0FF-4622-93C9-B7E75DC0E94EQ49320015-6B47C0AA-4213-4AF8-9970-2C3BC38421D9Q49990556-25F0ED60-1EAF-4410-B93F-47FDA5EEF894Q50054318-24655C54-5D39-41CA-B444-FAB3FDD8C7F2Q50280560-7AFBBCF8-0AF8-4CE5-84C5-7A3F302762CCQ50545820-85B183A9-4143-421D-A607-7A28C5F0DBF3
P2860
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
@en
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
@nl
type
label
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
@en
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
@nl
prefLabel
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
@en
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
@nl
P2093
P2860
P50
P921
P356
P1476
Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
@en
P2093
Hiroshi Kobayashi
Keiki Kumano
Keisuke Kataoka
Mineo Kurokawa
Shunya Arai
Taku Saito
Yuki Kagoya
P2860
P304
P356
10.1172/JCI68101
P407
P577
2014-01-02T00:00:00Z